FACACLASSIC

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”

HHS - 769 - Advisory Committee on Infant and Maternal Mortality - Authorized by Law

GENERAL INFORMATION

Committee Name	Advisory Committee on Infant and Maternal Mortality	Agency Name	Department of Health and Human Services
Fiscal Year	2025	Committee Number	769
Original Establishment Date	6/28/1991	Committee Status	Terminated
Actual Termination Date	4/1/2025	Committee URL	https://www.hrsa.gov/advisory-committees/Infant...
Actual Merged Date		Presidential Appointments*	No
New Committee This FY	No	Max Number of Members*	36
Terminated This FY	Yes	Designated Fed Officer Position Title*	Public Health Analyst/DFO
Merged This FY		Designated Federal Officer Prefix	Ms.
Current Charter Date	9/30/2023	Designated Federal Officer First Name*	Vanessa
Date Of Renewal Charter	9/30/2025	Designated Federal Officer Middle Name
Projected Termination Date		Designated Federal Officer Last Name*	Lee
Exempt From Renewal*	No	Designated Federal Officer Suffix	MPH
Specific Termination Authority	2025 Secretary Directive	Designated Federal Officer Phone*	(301) 443-9992
Establishment Authority*	Authorized by Law	Designated Federal Officer Fax*	(301) 594-0878
Specific Establishment Authority*	42 U.S.C. 217a	Designated Federal Officer Email*	vlee1@hrsa.gov
Effective Date Of Authority*	11/17/1962
Exempt From EO 13875 Discretionary Cmte	Not Applicable
Committee Type*	Continuing
Presidential*	No
Committee Function*	National Policy Issue Advisory Board

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*	Continue
Legislation to Terminate Required	Not Applicable
Legislation Status	Not Applicable
How does cmte accomplish its purpose?*	The Committee met three times in Fiscal Year (FY) 2024. Two meetings were held in-person, and one was held virtually via webinar. The in-person meetings were held in St. Louis, Missouri and at HRSA Headquarters in Rockville, Maryland. The Committee is comprised of both voting (public) members and non-voting ex-officio (federal) members.
How is membership balanced?*	The 21 public members of the Committee, including the Committee Chair, are selected by the Secretary, and a Committee Chair is selected among the members by the HRSA Administrator. Members from the private sector may represent advocacy organizations, corporations, foundations, health plans, and other stakeholder groups such as faith-based communities, consumers, health, and professional organizations. Members from the public sector may include elected officials and health and human services administrators from the state and local levels including representatives of minority, rural, and urban interests. The Committee also has federal ex-officio members that include: the Assistant Secretary for Health or designee; the Director of HHS Office on Women’s Health or designee; the Deputy Assistant Secretary for Minority Health/Director of the Office of Minority Health or designee; the HRSA Administrator or designee; the Director of the Centers for Disease Control and Prevention’s (CDC) Center on Birth Defects and Developmental Disabilities or designee; the Director of CDC’s Division of Reproductive Health or designee; a representative from the CDC’s National Center for Health Statistics; the Administrator for the Centers for Medicare & Medicaid Services or designee; the Assistant Secretary of the Administration for Children and Families or designee; a representative from the National Institutes of Health’s National Institute of Child Health and Human Development; a representative from the Indian Health Service; a representative from the Substance Abuse and Mental Health Services Administration; a representative from the U.S. Department of Agriculture – Food and Nutrition Services; a representative from the Department of Housing and Urban Development; a representative from the Department of Labor – Women’s Bureau; and any appropriately qualified representative of the Department of HHS or other agencies of the federal government designated by the Secretary as ex-officio members. The membership balance of the committee is not static and may change, depending on the work of the committee.
How frequent & relevant are cmte mtgs?*	Meetings are held approximately four times per year. Committee meetings are necessary to review current evidence and data, and to generate new ideas and recommendations in order to maintain progress on reducing infant and maternal deaths and disparities in infant/maternal mortality. This is addressed through the activities and efforts of a number of workgroups (that are formed on an ad hoc basis), and the discussion of new policies and scientific findings pertaining to maternal and infant health. In addition, the Committee continues to monitor and review the Healthy Start program and its evaluation, as well as Healthy People 2030 objectives. ACIMM advises the Secretary of the Department of Health and Human Services (HHS) on department activities, partnerships, policies, and programs directed at reducing infant mortality, maternal mortality and severe maternal morbidity, and improving the health status of infants and women before, during, and after pregnancy. The Committee provides advice on how best to coordinate federal, state, local, tribal, and territorial governmental efforts designed to improve infant mortality, related adverse birth outcomes, and maternal health, as well as influence similar efforts in the private and voluntary sectors. The Committee provides guidance and recommendations on the policies, programs, and resources required to address the disparities and inequities in infant mortality, related adverse birth outcomes and maternal health outcomes, including maternal mortality and severe maternal morbidity. With its focus on underlying causes of the disparities and inequities seen in birth outcomes for women and infants, the Committee advises the Secretary on the health, social, economic, and environmental factors contributing to the inequities and proposes structural, policy, and/or systems level changes.
Why advice can't be obtained elsewhere?*	This Committee is necessary to provide the HHS with ongoing counsel and advice from a broad range of public and private sector expertise not available within HHS. The work of the Committee is especially important in light of the continued rise in preterm births, a major contributor to infant mortality, and the maternal health crisis in the U.S. There is an increased focus and attention on maternal health, maternal mortality, and severe maternal morbidity. In addition disparities in infant and maternal outcomes are persistent and must be addressed.
Why close or partially close meetings?	N/A - ACIMM meetings are open to the public.
Recommendation Remarks	Per 2025 Secretary Directive this FACA Committee has been terminated. Member Tara Lee's term end date changed from 12/31/2024 to 10/17/2023 due to resignation from ACIMM. Ex-Officio Iris Mabry-Hernandez term end date changed from 12/31/2024 to 9/29/2023 due to AHRQ no longer being listed in the 2023-2025 Charter as an Ex-officio. Ex-Officio Kamila Mistry term end date changed from 12/31/2025 to 9/29/2023 due to AHRQ no longer being listed in the 2023-2025 Charter as an Ex-officio. Ex-Officio Paul Kesner term end date changed from 12/31/2024 to 9/29/2023 due to Dept. of Education no longer being listed in the 2023-2025 Charter as an Ex-officio. Ex-Officio Suzanne England term end date changed from 12/31/2024 to 10/1/2023 due to Tina Pattara-Lau replacing them from IHS. Ex-Officio Wendy DeCourcey term end date changed from 12/31/2024 to 5/31/2024 due to Anne Miller replacing them from ACF. Ex-Officio member from HHS-OASH added: Deborah Kilday. Ex-Officio member from SAMHSA added: Nima Sheth. Ex-Officio member from HHS-Office of Minority Health added: RDML Felicia Collins Six new public members were appointed by HHS with term start date of June 16, 2024: Ndidiamaka Amutah-Onukagha, Hannabah Blue, Charleta Guillory, Marilyn Kacica, Scott Lorch, and Marya Zlatnik.

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*	Yes	Action Reorganize Priorities*	Yes
Outcome Trust In Government	No	Action Reallocate Resources	Yes
Outcome Major Policy Changes	Yes	Action Issued New Regulations	No
Outcome Advance In Scientific Research	No	Action Proposed Legislation	No
Outcome Effective Grant Making	No	Action Approved Grants Or Other Payments	No
Outcome Improved Service Delivery	Yes	Action Other	No
Outcome Increased Customer Satisfaction	No	Action Comment	NA
Outcome Implement Laws/Reg Requirements	No	Grants Review*	No
Outcome Other	No	Number Of Grants Reviewed	0
Outcome Comment		Number Of Grants Recommended	0
Cost Savings*	Unable to Determine	Dollar Value Of Grants Recommended	$0.00
Cost Savings Comment	NA	Grants Review Comment	NA
Number Of Recommendations*	151	Access Contact Designated Fed. Officer*	Yes
Number Of Recommendations Comment	No new recommendations were made in FY2024.	Access Agency Website	Yes
% of Recs Fully Implemented*	15.00%	Access Committee Website	Yes
% of Recs Fully Implemented Comment	The Committee submitted recommendations to improve American Indian/Alaska Native (AI/AN) birth outcomes in December of 2022. They were reviewed by the Department and continue to be used as agencies think about national efforts and activities across the Department to improve the health and well-being of AI/AN mothers and infants. The ex-officio members met three times (December 2023, April and June 2024) to discuss progress on implementation/adoption of the recommendations in their respective agencies, and they report out at each Committee meeting on activities being undertaken related to the AI/AN recommendations. The DFO and ACIMM Program Lead continue to monitor and assess what recommendations are fully and partially implemented, as well as any that are not feasible. 9 (or 1 additional) of the AI/AN recommendations were fully implemented in FY2024.	Access GSA FACA Website	Yes
% of Recs Partially Implemented*	58.00%	Access Publications	No
% of Recs Partially Implemented Comment	The Committee submitted recommendations to improve American Indian/Alaska Native (AI/AN) birth outcomes in December of 2022. They were reviewed by the Department and continue to be used as agencies think about national efforts and activities across the Department to improve the health and well-being of AI/AN mothers and infants. The ex-officio members met three times (Dec. 2023, April and June 2024) to discuss progress on implementation/adoption of the recommendations in their respective agencies, and they report out at each Committee meeting on activities being undertaken related to the AI/AN recommendations. The DFO and ACIMM Program Lead continue to monitor and assess what recommendations are fully and partially implemented, as well as any that are not feasible. 28 (or 3 additional) of the AI/AN recommendations were partially implemented in FY2023.	Access Other	No
Agency Feedback*	Yes	Access Comment
Agency Feedback Comment*	The agency provides feedback to the Committee through letters/official written correspondence, which gets posted on the ACIMM website (https://www.hrsa.gov/advisory-committees/infant-mortality/letters) – this is where the public can obtain information on agency feedback. Feedback may also be provided by the Designated Federal Official and/or federal ex-officio members at Committee meetings, which would be captured in the meeting recordings, transcripts, and meeting minutes. These are also all posted on the ACIMM website following a Committee meeting, and accessible to the public. The Committee did not submit any new recommendations in FY2024. However, the Executive Secretary of the Committee, federal Ex-Officio members, and the Designated Federal Official provided updates at each committee meeting in FY2024 on progress related to adoption or implementation of the Committee's past recommendations to HHS - specifically the 2022 recommendations to improve American Indian/Alaska Native (AI/AN) birth outcomes.	Narrative Description*

COSTS

1. Payments to Non-Federal Members*	$0.00	1. Est Paymnts to Non-Fed Membrs Nxt FY*	$0.00
2. Payments to Federal Members*	$0.00	2. Est. Payments to Fed Members Next FY*	$0.00
3. Payments to Federal Staff*	$0.00	3. Estimated Payments to Federal Staff*	$0.00
4. Payments to Consultants*	$0.00	4. Est. Payments to Consultants Next FY*	$0.00
5. Travel Reimb. For Non-Federal Membrs*	$0.00	5. Est Travel Reimb Non-Fed Membr nxtFY*	$0.00
6. Travel Reimb. For Federal Members*	$0.00	6. Est Travel Reimb For Fed Members*	$0.00
7. Travel Reimb. For Federal Staff*	$0.00	7. Est. Travel Reimb to Fed Staf Nxt FY*	$0.00
8. Travel Reimb. For Consultants*	$0.00	8. Est Travel Reimb to Consltnts Nxt FY*	$0.00
10. Other Costs	$0.00	10. Est. Other Costs Next FY*	$0.00
11. Total Costs	$0.00	11. Est. Total Next FY*	$0.00
Date Cost Last Modified	4/17/2025 11:08 AM	Est. Fed Staff Support Next FY*
Federal Staff Support (FTE)*		Est Cost Remarks
Cost Remarks

Interest Areas

Category Area Basic Science Basic Sciences Business Small Business Civil Rights Children Civil Rights Disabled Equal Opportunity Minorities Native Americans Women Computer Technology Information Technology Data Data Quality Education Education Training Eligibility Eligibility Programs Social Services Welfare Environment Environmental Issues Federal Employment Public Services Food and Drugs Food and Drugs Government Federal Government State Government Tribal Government Health Health Care Hospitals Medical Education Medical Practitioners Nutrition Nutrition for Women, Infants and Children Physical Fitness Public Health Safety Treatment Housing and Urban Housing and Urban Development Justice Drug Abuse Policy and Enforcement Justice Juvenile Justice Prevention Research and Statistics Labor Employment Job Training Wages Workforce and Occupations Medicine Diseases Health and Health Research Illnesses Medicine and Dentistry Research Research and Statistics

Custom Links

Committee Level Reports